Global Implantable Remote Patient Monitoring Devices Market
상품코드:1708110
리서치사:BCC Research
발행일:2025년 04월
페이지 정보:영문 140 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 이식형 원격 환자 모니터링(IRPM) 디바이스 시장 규모는 2023년 65억 달러, 2024년 76억 달러에서 예측 기간 중 CAGR 21.7%로 추이하며, 2029년말에는 203억 달러로 성장할 것으로 예측됩니다.
북미 시장은 2024년 27억 달러에서 19.5%의 CAGR로 추이하며, 2029년말에는 67억 달러로 성장할 것으로 예측됩니다. 아시아태평양 시장은 2024년 20억 달러에서 24.3%의 CAGR로 추이하며, 2029년말에는 59억 달러로 성장할 것으로 예측됩니다.
세계의 이식형 원격 환자 모니터링(IRPM) 디바이스 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회의 분석, 법규제 환경, 신규 기술 및 기술개발의 동향, 시장 규모 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 개요
시장 전망
조사 범위
시장 요약
제2장 시장 개요
개요
PESTEL 분석
Porter's Five Forces 분석
공급망 분석
제3장 시장 역학
시장 역학 개요
시장 성장 촉진요인
만성질환의 증가와 인구의 고령화
모바일 헬스 애플리케이션의 수요 증가
무선통신 기술의 향상
시장 성장 억제요인
데이터 프라이버시에 관한 우려
엄격한 정부 규제
시장 기회
신흥 시장
시장이 해결해야 할 과제
헬스케어 시스템과의 통합
제4장 규제 상황
규제 프레임워크
미국
EU
일본
제5장 신규 기술과 개발
이식형 원격 환자 모니터링(IRPM) 디바이스 시장에서의 신규 기술
AI와 기계학습
나노테크놀러지 기반 디바이스
생체 적합성 재료
특허 분석
특허 : 연별
특허 : 주요 출원인별
특허 : 주요 오너별
특허 : 주요 발명자별
특허 : 관할별
제6장 시장 부문 분석
세분화 내역
IRPM 디바이스 : 세계 시장
시장 분석 : 제품별
이식형 심혈관 모니터링 디바이스
이식형 뇌 모니터링 디바이스
위장 모니터링(스마트 필)
이식형 혈액 모니터링 디바이스
이식형 호흡 모니터링 디바이스
이식형 근골격 모니터링 디바이스
기타
시장 분석 : 적응증별
심혈관질환
뇌 장애
소화기 질환
당뇨병
만성 호흡기질환
근골격계 질환
기타
시장 분석 : 최종사용자별
병원·진료소
재택 헬스케어
기타
지역적 내역
시장 분석 : 지역별
북미
유럽
아시아태평양
기타 지역
제7장 지속가능성 : IRPM 디바이스에서 ESG의 관점
IRPM 디바이스 업계에서의 지속가능성
ESG 데이터의 이해
BCC에 의한 결론
제8장 경쟁 정보
개요
IRPM 디바이스 제조업체의 주요 전략
유통 네트워크
제품 지도제작
제9장 부록
조사 방법
약어
전시
기업 개요
ABBOTT
AVERTIX MEDICAL INC.
BIOTRONIK
BOSTON SCIENTIFIC CORP.
CARDIAC RMS
DEXCOM INC.
EBR SYSTEMS INC.
ENDOTRONIX INC.
INJECTSENSE INC.
IMPULSE DYNAMICS
MEDICO S.R.L.
MEDTRONIC
PROFUSA INC.
QURA LLC.
VITALCONNECT
KSA
영문 목차
영문목차
The global market for implantable remote patient monitoring (IRPM) devices was valued at $6.5 billion in 2023. The market is expected to grow from $7.6 billion in 2024 to $20.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 21.7% from 2024 to 2029.
The North American market for IRPM devices is expected to grow from $2.7 billion in 2024 to $6.7 billion by the end of 2029, at a CAGR of 19.5% from 2024 to 2029.
The Asia-Pacific market for IRPM devices is expected to grow from $2.0 billion in 2024 to $5.9 billion by the end of 2029, at a CAGR of 24.3% from 2024 to 2029.
Report Scope
The current report provides detailed information about the market's implantable remote patient monitoring (IRPM) devices. It provides market projections through 2029 and market ranks for key players. The report details the market share of IRPM devices based on product, indication and end users. This market is segmented into implantable cardiovascular monitoring devices, implantable brain monitoring devices, gastrointestinal monitoring (smart pills), implantable hematological monitoring devices, implantable respiratory monitoring devices, implantable musculoskeletal monitoring devices and others based on product. Based on indication, the market is segmented into cardiovascular diseases, brain disorders, gastrointestinal diseases, diabetes, chronic respiratory diseases, musculoskeletal diseases, and others. By end user, the market is categorized into hospitals and clinics, home healthcare settings, and others. A detailed competitive landscape includes major players, market share and recent strategic developments.
Additionally, the report offers a regional analysis, breaking down market trends and growth prospects across different geographical areas. It includes market forecasts, consumer insights, and a thorough supply chain analysis, addressing distribution channels and key suppliers. By examining these elements, the report aims to provide a comprehensive view of the market's current state and future potential, assisting stakeholders in making well-informed decisions and identifying strategic opportunities within the IRPM devices industry.
Report Includes
32 data tables and 47 additional tables
An overview of the global market for implantable remote patient monitoring (IRPM) devices
Analyses of the global market trends, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
Estimates of the market size and revenue forecast for the global market, and a corresponding market share analysis by product, indication, end user, and region
Discussion of the underlying opportunities in the implantable remote patient monitoring devices market, with the integration of internet of things (IoT) and wireless technologies for the diagnosis and treatment of diseases
Assessment of factors driving the industry's growth, current trends, market opportunities and restraints, and the technological advances that will shape the future market
Market share analysis of the major global corporations, the competitive landscape, product developments, marketing strategies and revenue forecasts
A discussion of the industry's ESG challenges and practices
Emphasis on the increasingly stringent government regulations as well as the increasing adoption of miniaturized multi-sensing devices in chronic disease management and self-health management
Latest information on mergers and acquisitions, partnerships, agreements, collaborations, and other strategic alliances
Identification of the major stakeholders and analysis of recent developments and segmental revenues
Profiles of the leading companies, including Boston Scientific Corp., Medtronic, Abbott Laboratories, Dexcom Inc., and Biotronik
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
PESTEL Analysis
Political
Economic
Social
Technological
Environmental
Legal
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competition in the Industry
Supply Chain Analysis
R&D, Product Design and Early Prototyping
Regulatory Submissions and Approvals
Raw Material Procurement
Manufacturing IRPM Devices
Distribution and Sales
Post-Sales Services
Chapter 3 Market Dynamics
Market Dynamics Overview
Market Drivers
Increasing Prevalence of Chronic Diseases and an Aging Population
Growing Demand for mHealth Applications
Improved Wireless Communication Technologies
Market Restraints
Data Privacy Concerns
Stringent Government Regulations
Market Opportunities
Emerging Markets
Market Challenges
Integration with Healthcare Systems
Chapter 4 Regulatory Landscape
Regulatory Framework
United States
European Union
Japan
Chapter 5 Emerging Technologies and Developments
Emerging Technologies in the IRPM Devices Market
Artificial Intelligence and Machine Learning
Nanotechnology-based Devices
Biocompatible Materials
Patent Analysis
Patents by Year
Patents by Top Applicant
Patents by Top Owner
Patents by Top Inventor
Patents by Jurisdiction
Chapter 6 Market Segment Analysis
Segmentation Breakdown
IRPM Devices: Global Markets
Market Analysis by Product
Implantable Cardiovascular Monitoring Devices
Implantable Brain Monitoring Devices
Gastrointestinal Monitoring (Smart Pills)
Implantable Hematological Monitoring Devices
Implantable Respiratory Monitoring Devices
Implantable Musculoskeletal Monitoring Devices
Others
Market Analysis by Indication
Cardiovascular Diseases
Brain Disorders
Gastrointestinal Diseases
Diabetes
Chronic Respiratory Diseases
Musculoskeletal Diseases
Others
Market Analysis by End User
Hospital and Clinics
Home Healthcare Settings
Other End-users
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Sustainability: An ESG Perspective in IRPM Devices
